|
ATF6B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.022300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.442700E-04 |
| Normal-vs-Stage2 |
1.844580E-01 |
| Normal-vs-Stage3 |
8.941400E-03 |
| Normal-vs-Stage4 |
2.575400E-03 |
| Stage1-vs-Stage2 |
2.145600E-01 |
| Stage1-vs-Stage3 |
7.135000E-01 |
| Stage1-vs-Stage4 |
3.530200E-01 |
| Stage2-vs-Stage3 |
4.202600E-01 |
| Stage2-vs-Stage4 |
1.354770E-01 |
| Stage3-vs-Stage4 |
2.313200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.158200E-03 |
| Normal-vs-AfricanAmerican |
1.310120E-02 |
| Normal-vs-Asian |
8.165600E-02 |
| Caucasian-vs-AfricanAmerican |
6.228800E-01 |
| Caucasian-vs-Asian |
8.937200E-01 |
| AfricanAmerican-vs-Asian |
7.430400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.550500E-04 |
| Normal-vs-Female |
6.947600E-02 |
| Male-vs-Female |
9.822500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.055900E-02 |
| Normal-vs-Extreme_Weight |
4.221300E-04 |
| Normal-vs-Obese |
2.093500E-02 |
| Normal-vs-Extreme_Obese |
4.759600E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.871000E-01 |
| Normal_Weight-vs-Obese |
9.098800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.888400E-02 |
| Extreme_Weight-vs-Obese |
1.915800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.539400E-01 |
| Obese-vs-Extreme_Obese |
8.500500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.283900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.149800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.342000E-03 |
| Normal-vs-Age(81-100Yrs) |
8.766100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.939000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.271400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.802610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.246770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.306100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.289800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.615800E-03 |
| Normal-VS-Type2 PRCC |
3.57560000000534E-05 |
| Normal-VS-KIRP CIMP |
3.836400E-04 |
| Normal-VS-Unclassified PRCC |
4.335900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.522400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.756100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.149600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.735200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.920300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.715600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68739999999645E-05 |
| Normal-vs-N1 |
1.743570E-01 |
| Normal-vs-N2 |
7.05470000195163E-08 |
| N0-vs-N1 |
2.187400E-01 |
| N0-vs-N2 |
9.702100E-02 |
| N1-vs-N2 |
2.057900E-03 |
|
|
